# Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial

> **NCT07491783** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sichuan Enray Pharmaceutical Sciences Company** · enrollment: 52 (estimated)

## Conditions studied

- HNSCC
- Soft Tissue Cancer

## Interventions

- **DRUG:** Carbon Nanoparticle Iron Suspension for Injection

## Key facts

- **NCT ID:** NCT07491783
- **Lead sponsor:** Sichuan Enray Pharmaceutical Sciences Company
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-27
- **Primary completion:** 2027-12-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2026-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07491783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07491783, "Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07491783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*